Golden State Equity Partners’s Medpace MEDP Stock Holding History

Golden State Equity Partners’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-29	Closed	-$13.9K	–	1163
2026 Q1	$13.9K	Buy	+29	New	+$14.8K	﹤0.01%	1206

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Golden State Equity Partners's MEDP Position: Q2 2026 in Review

Golden State Equity Partners sold out of Medpace (MEDP) in Q2 2026, closing a stake of 29 shares — an estimated $13.9K sold.

Golden State Equity Partners first reported a position in MEDP in Q1 2026 and held it in 1 quarter. The position peaked at $13.9K in Q1 2026. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

Golden State Equity Partners reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
Golden State Equity Partners sold 29 Medpace shares in Q2 2026, an estimated $13.9K.
Golden State Equity Partners first reported a position in Medpace in Q1 2026 and held it in 1 quarter.
Golden State Equity Partners's Medpace position peaked at $13.9K in Q1 2026.
697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.